ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP Last Month

November 25, 2011

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Funding opportunities listed.

September 17, 2004

In Brief: Senate Markup Of Cancer Act Renewal Bill Delayed Again; New Money Levels Considered Still Too Low

November 9, 1979

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

Yates Named DRCCA AD To Head Centers, CCOP, Organ Sites: CCOP Workshops Listed

February 26, 1982